Final report on the safety assessment of calendula officinalis extract and calendula officinalis

International Journal of Toxicology

Volumn 20, Issue 2_suppl, 2001, Pages 13-20

  Fiume, Monice Zondlo ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTANEDIOL; CALENDULA OFFICINALIS EXTRACT; CARBOHYDRATE; CAROTENOID; COSMETIC; ESSENTIAL OIL; FLAVONOID; PHENOL; PLANT EXTRACT; POLYPRENYLQUINONE; PROPYLENE GLYCOL; QUINONE DERIVATIVE; RESIN; SAPONIN; SOYBEAN OIL; STEROL; UNCLASSIFIED DRUG; VITAMIN;

ABSORPTION; ACUTE TOXICITY; AMES TEST; ANALYTIC METHOD; ARTICLE; CALENDULA OFFICINALIS; CARCINOGENICITY; CHEMICAL COMPOSITION; CLINICAL ASSESSMENT; CYTOTOXICITY; DEVELOPMENTAL TOXICITY; DROSOPHILA MELANOGASTER; DRUG IMPURITY; EXCRETION; EXTRACTION; EYE IRRITATION; FLOWER; GENOTOXICITY; HISTOPATHOLOGY; IMMUNOLOGY; LIGHT ABSORPTION; METABOLISM; MUCILAGE; NONHUMAN; PARTICLE SIZE; PHOTOSENSITIZATION; PHOTOTOXICITY; PHYSICAL CHEMISTRY; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; SKIN IRRITATION; SKIN SENSITIZATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ANIMAL; CALENDULA; CARCINOGEN TESTING; CHEMICALLY INDUCED DISORDER; CHEMISTRY; EYE DISEASE; GENETICS; INTRADERMAL DRUG ADMINISTRATION; MOUSE; MUTAGEN TESTING; PHOTOCHEMISTRY; PHOTOSENSITIVITY DISORDER; RAT; REVIEW; SAFETY; SKIN DISEASE; TOXICITY TESTING; ULTRAVIOLET RADIATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; CALENDULA; CARCINOGENICITY TESTS; COSMETICS; DROSOPHILA MELANOGASTER; EYE DISEASES; MICE; MUTAGENICITY TESTS; PHOTOCHEMISTRY; PHOTOSENSITIVITY DISORDERS; PLANT EXTRACTS; RATS; SAFETY; SKIN DISEASES; TOXICITY TESTS; ULTRAVIOLET RAYS;

EID: 0012891154     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810152902556     Document Type: Article

References (40)

1. Bezákova, L., I. Mašterová Paulíková and M. Pšenák. 1996. Inhibitory activity of isorhamnetin glycosides from Calendula officinalis L. on the activity of lipoxygenase. Pharmazie 51: 126-7.
2. Boucaud-Maitre, Y., O. Algernon, and J. Raynaud. 1988. Cytotoxic and antitumoral activity of Calendula officinalis extracts. Pharmazie 43: 220-221.
3. Bruynzeel, D. P., W. G. van Ketel, E. Young, T. van Joost, and G. Smeenk. 1992. Contact sensitization by alternative topical medicaments containing plant extracts. Contact 27: 278-279.
4. Budavari, S., ed. 1989. The Merck index. An encyclopedia of chemicals, drugs, and biologicals, 11th ed., 258. Rahway, NJ: Merck & Co.
5. Chemisches Laboratorium Dr. Kurt Richter GmbH. 1996. Raw material documentation on Calendula Oil CLR (Calendula Officinalis Extract and soybean (Glycine Soja) oil and tocopherol). Unpublished data submitted by CTFA. (7 pages.)4
6. Cosmetic, Toiletry, and Fragrance Association (CTFA). 1980. Acute oral toxicity of Calendula Officinalis Extract. Unpublished data submitted by CTFA. (1 page.)4
7. CTFA. 1983. Skin and ocular irritation studies on 10% Calendula Officinalis Extract. Unpublished data submitted by CTFA. (2 pages.)4
8. CTFA. 1984. Modified Magnusson-Kligman guinea pig maximization test for contact sensitization of Calendula Officinalis Extract. Study project GPA-01-84. Final report dated May 14. Unpublished data submitted by CTFA. (20 pages.)4
9. CTFA. 1986a. Dermal and ocular irritation studies and a human patch test on eye products containing 1% Calendula Officinalis Extract. Unpublished data submitted by CTFA. (4 pages.)4
10. CTFA. 1986b. Allergic contact sensitization test on eye cream 38425-12 containing 1.0% Calendula Officinalis Extract (RI3459). Unpublished data submitted by CTFA. (7 pages.)4
11. CTFA. 1990. Four-day mini-cumulative irritancy assay of an eye product containing 1% Calendula Officinalis Extract. Unpublished data submitted by CTFA. (1 page.)4
12. CTFA. 1998. Concentration of use data on Arnica Montana Extract. Unpublished data submitted by CTFA. (1 page.)4
13. Cosmetics Directive of the European Union. (1995) Updated version-Incorporating all amendments until August 1, 1995. Dir. 76/768/EEC.
14. de Groot, A. C., D. P. Bruynzeel, J. D. Bos, et al. 1988. The allergens in cosmetics. Arch. Dermatol. 124: 1525-1529.
15. Delia Loggia, R., A. Tubaro, S. Sosa, H. Becker, St. Saar, and O. Isaac. 1994. The role of triterpenoids in the topical anti-inflammatory activity of Calendula officinalis flowers. Planta Med. 60: 516-520.
16. Dhar, M. L., M. M. Shar, B. N. Dhawan, B. N. Mehrotra, and C. Ray. 1968. Screening of Indian plants for biological activity: Part I. Indian J. Exp. Biol. 6: 232-247.
17. Elias, R., M. DeMéo, E. Vidal-Ollivier, M. Laget, G. Balansard, and G. Dumenil. 1990. Antimutagenic activity of some saponins isolated from Calendula officinalis L., C. arvensis L., and Hedera helix L. Mutagenesis 5: 327-331.
18. Fleischner, A. M. 1985. Plant extracts: To accelerate healing and reduce inflammation. Cosmetics Toilet. 100: 45-46, 48-51, 54-55, 58.
19. Food and Drug Administration (FDA). 1984. Cosmetic product formulation and frequency of use data. FDA database. Washington, DC: FDA.
20. FDA. 1992. Modification in voluntary filing of cosmetic product ingredient and cosmetic raw composition statements. Fed. Register 57: 3128-3130.
21. FDA. 1997. Spices and other natural seasoning sand flavorings. Code of Federal Regulations, Title 21, §182.10.
22. FDA. 1998. Frequency of use of cosmetic ingredients. FDA database. Washington, DC: FDA.
23. Góra, J., D. Kalemba, A. Kurowska, and L. Świtek. 1980. Chemical substances from influorescences of Arnica montana L. and Calendula officinalis L. soluble in isopropyl myristate and propylene glycol. Herba Hung. 19: 165-171.
24. Gracza L. 1987. Oxygen-containing terpene derivatives from Calendula officinalis. Planta Med. 53: 227.
25. Graf, U., A. Alonso Moraga, R. Castro, and E. Díaz Carrillo. 1994. Genotoxicity testing of different types of beverages in the Drosophila wing somatic mutation and recombination test. Food Chem. Toxicol. 32: 423-430.
26. Grau Aromatics GmbH & Co. 1998. Specifications of Calendula Extract HS 2380 G (Calendula Officinalis Extract and propylene glycol). Unpublished data submitted by CTFA. (1 page.)4
27. Hilltop Research. 1986. Report of a human skin test of cumulative irritation on formula #38425-08 containing 1.0% Calendula Extract (RI3459). Study 86-0652-74 dated July 11. Unpublished data submitted by CTFA. (15 pages.)4
28. Ichimaru Pharcos Co., Ltd. 1994. Specifications of Toukinsenka Liquid (Calendula Officinalis Extract and butylene glycol and water.) Unpublished data submitted by CTFA. (5 pages.)4
29. Klouček-Papova, E., A. Popov, N. Pavlova, and S. Krusteva. 1982. Influence of the physiological regeneration and epithelialization using fractions isolated from Calendula officinalis. Acta Physiol. Pharmacol. Bulgarica 8: 63-67.
30. Paulsen, E., K. E. Andersen, and B. M. Hausen. 1993. Compositae dermatitis in a Danish dermatology department in one year. Contact Dermatitis 29: 6-10.
31. Pietta, P., A. Bruno, P. Mauri, and A. Rava. 1992. Separation of flavonol-2-O-glycosides from Calendula officinalis and Sambucus nigra by high-performance liquid and micellar electrokinetic capillary chromatography. J. Chromatogr. 593: 165-170.
32. Rempe, J. M., and L. G. Santucci. 1997. CTFA list of Japanese cosmetic ingredients, 3rd ed., 16. Washington, DC: CTFA.
33. Rodríquez, E., and J. C. Mitchell. 1977. Absence of contact hypersensitivity to some perfume materials derived from Compositae species. Contact Dermatitis 3: 168-169.
34. TKL Research. 1987. Repeated insult patch test of product #38425-22 containing 1.0% Calendula Extract (RI3459). Study #871000. Unpublished data submitted by CTFA. (11 pages.)4
35. Vidal-Ollivier, E., A. M. Diaz-Lanza, G. Balansard, C. Maillard, and J. Vaillant. 1990. Dosage des saponosides de Calendula officinalis L. en fonction de la variété culturale et de lat date de récolte. Pharm. Acta Helv. 65: 236-238. (English abstract.)
36. Vidal-Ollivier, E., R. Elias, F. Crespin, A. M. Diaz Lanza, C. Maillard, and G. Balansard. 1991. Dosage par C.L.H.P. des flavonoödes majoritaires de Calendula officinalis L. en fonction de la variété culturale et de la date de récolte. Pharm. Acta Helv. 66: 318-320. (English abstract.)
37. Wagner, V. H., A. Proksch, I. Riess-Maurer et al. 1985. Immunostimulating polysaccharides (heteroglycans) from higher plants. Arzneim. Forsch. 35: 1069-1075. (Translated from German.)
38. Wenninger, J. A., and G. N. McEwen Jr., eds. 1997. International cosmetic ingredient dictionary and handbook, 7th ed. Vol. 1, 186-187. Washington, DC: CTFA.
39. Wojciechowski, Z. A., and J. Zimowski. 1975. Acyl composition and biosynthesis of acylated steryl glucosides in Calendula officinalis. Biochim. Biophys. Acta 398: 111-117.
40. Wrangsjö K., A. M. Ros, and J. E. Wahlberg 1990. Contact allergy to Compositae plants in patients with summer-exacerbated dermatitis. Contact Dermatitis 22: 148-154.